Lucy Knight

Somerset Partnership NHS Foundation Trust — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index864citations61works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(8), Dementia and Cognitive Impairment Research(7), Total Knee Arthroplasty Outcomes(7), Alzheimer's disease research and treatments(6), RNA modifications and cancer(6)

Publications61 total

Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial
Nature Medicine·2025· 5 citedOpen Access
THE EFFECT OF DISPLACEMENT RATE ON THE AXIAL LOAD CAPACITY OF STEEL RODS GLUED INTO GLULAM BEAMS
2025
Do glial‐reactivity and cerebral blood flow modulate cerebral glucose metabolism in Alzheimer’s disease?
Alzheimer s & Dementia·2024Open Access
A service evaluation of measuring fluid responsiveness in acutely unwell hypotensive patients outside of critical care
Intensive and Critical Care Nursing·2024· 2 cited
Dysfunctional cerebral glucose transport in Alzheimer’s Disease
Alzheimer s & Dementia·2023· 1 citedOpen Access
MRI CHANGES FOLLOWING TREATMENT OF GLP‐1 ANALOGUE, LIRAGLUTIDE IN ALZHEIMER’S DISEASE
Alzheimer s & Dementia·2023· 17 citedOpen Access
Magnetic Resonance Spectroscopy metabolites as biomarkers of Alzheimer’s Disease
Alzheimer s & Dementia·2023Open Access
Supplementary Materials and Methods from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Figures S1-S6 and Immunoblots from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S1 from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure Legends for S1 - S6 from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Table S1 from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Materials and Methods from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Figures S1-S6 and Immunoblots from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Data from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Data from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure Legends for S1 - S6 from AGO2 Mediates <i>MYC</i> mRNA Stability in Hepatocellular Carcinoma
2023Open Access
P002 Advice line ... of duty
Lara D. Veeken·2022Open Access
Evaluation of liraglutide in the treatment of Alzheimer's disease
Alzheimer s & Dementia·2021· 64 cited
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?
Alzheimer s Research & Therapy·2021· 54 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Grazia Daniela Femminella(14), Clive Holmes(14), Craig Ritchie(14), Brady McFarlane(14), George Tadros(14), Basil H. Ridha(14), Hilary Archer(14), Elizabeth Coulthard(14), Benjamin R. Underwood(14), Aparna Prasanna(14), Paul Koranteng(14), Salman Karim(14), Kehinde Junaid(14), Bernadette McGuinness(14), Ramin Nilforooshan(14), Simon Thacker(14), Vandana Mate(14), Sajeev Kshemendran(14), Anthony Peter Passmore(14), Clive Ballard(14)